Cargando…
Primary Antimicrobial Susceptibility Changes in Children with Helicobacter pylori Infection over 13 Years in Northern Italy
The eradication therapy of Helicobacter pylori (H. pylori) infection is still a challenge for gastroenterologists. One of the main causes of failure in H. pylori eradication is the antibiotic resistance mainly to clarithromycin. Culture from biopsies is maybe the most used method among the antimicro...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438156/ https://www.ncbi.nlm.nih.gov/pubmed/26064096 http://dx.doi.org/10.1155/2015/717349 |
_version_ | 1782372285516087296 |
---|---|
author | Manfredi, Marco Gismondi, Pierpacifico Maffini, Valentina Bizzarri, Barbara Fornaroli, Fabiola Madia, Carmen Salerno, Antonino Cangelosi, A. Marta de'Angelis, Gian Luigi |
author_facet | Manfredi, Marco Gismondi, Pierpacifico Maffini, Valentina Bizzarri, Barbara Fornaroli, Fabiola Madia, Carmen Salerno, Antonino Cangelosi, A. Marta de'Angelis, Gian Luigi |
author_sort | Manfredi, Marco |
collection | PubMed |
description | The eradication therapy of Helicobacter pylori (H. pylori) infection is still a challenge for gastroenterologists. One of the main causes of failure in H. pylori eradication is the antibiotic resistance mainly to clarithromycin. Culture from biopsies is maybe the most used method among the antimicrobial susceptibility techniques. In this study, we compared the antimicrobial susceptibility changes in children with H. pylori infection over 13 years and we confirmed that clarithromycin resistance has been increased (16% versus 26%) though with no statistically signficant value. Therefore, clarithromycin should not be used in empiric treatment of H. pylori eradication therapy in children, but its use should be limited only to children with known antimicrobial susceptibility. On the other hand, metronidazole resistance has decreased over this time period in statistically significant manner (56% versus 33%, p = 0.014). Furthermore, ampicillin resistance has been confirmed to be very rare (3% versus 0%) in children with H. pylori infection. In conclusion, in H. pylori infection, if we do not know the antibiotic susceptibility of patients, we should recommend an eradication therapy based on the local distribution of antibiotic resistance rates trying to limit the therapeutic failures. |
format | Online Article Text |
id | pubmed-4438156 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-44381562015-06-10 Primary Antimicrobial Susceptibility Changes in Children with Helicobacter pylori Infection over 13 Years in Northern Italy Manfredi, Marco Gismondi, Pierpacifico Maffini, Valentina Bizzarri, Barbara Fornaroli, Fabiola Madia, Carmen Salerno, Antonino Cangelosi, A. Marta de'Angelis, Gian Luigi Gastroenterol Res Pract Research Article The eradication therapy of Helicobacter pylori (H. pylori) infection is still a challenge for gastroenterologists. One of the main causes of failure in H. pylori eradication is the antibiotic resistance mainly to clarithromycin. Culture from biopsies is maybe the most used method among the antimicrobial susceptibility techniques. In this study, we compared the antimicrobial susceptibility changes in children with H. pylori infection over 13 years and we confirmed that clarithromycin resistance has been increased (16% versus 26%) though with no statistically signficant value. Therefore, clarithromycin should not be used in empiric treatment of H. pylori eradication therapy in children, but its use should be limited only to children with known antimicrobial susceptibility. On the other hand, metronidazole resistance has decreased over this time period in statistically significant manner (56% versus 33%, p = 0.014). Furthermore, ampicillin resistance has been confirmed to be very rare (3% versus 0%) in children with H. pylori infection. In conclusion, in H. pylori infection, if we do not know the antibiotic susceptibility of patients, we should recommend an eradication therapy based on the local distribution of antibiotic resistance rates trying to limit the therapeutic failures. Hindawi Publishing Corporation 2015 2015-05-06 /pmc/articles/PMC4438156/ /pubmed/26064096 http://dx.doi.org/10.1155/2015/717349 Text en Copyright © 2015 Marco Manfredi et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Manfredi, Marco Gismondi, Pierpacifico Maffini, Valentina Bizzarri, Barbara Fornaroli, Fabiola Madia, Carmen Salerno, Antonino Cangelosi, A. Marta de'Angelis, Gian Luigi Primary Antimicrobial Susceptibility Changes in Children with Helicobacter pylori Infection over 13 Years in Northern Italy |
title | Primary Antimicrobial Susceptibility Changes in Children with Helicobacter pylori Infection over 13 Years in Northern Italy |
title_full | Primary Antimicrobial Susceptibility Changes in Children with Helicobacter pylori Infection over 13 Years in Northern Italy |
title_fullStr | Primary Antimicrobial Susceptibility Changes in Children with Helicobacter pylori Infection over 13 Years in Northern Italy |
title_full_unstemmed | Primary Antimicrobial Susceptibility Changes in Children with Helicobacter pylori Infection over 13 Years in Northern Italy |
title_short | Primary Antimicrobial Susceptibility Changes in Children with Helicobacter pylori Infection over 13 Years in Northern Italy |
title_sort | primary antimicrobial susceptibility changes in children with helicobacter pylori infection over 13 years in northern italy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438156/ https://www.ncbi.nlm.nih.gov/pubmed/26064096 http://dx.doi.org/10.1155/2015/717349 |
work_keys_str_mv | AT manfredimarco primaryantimicrobialsusceptibilitychangesinchildrenwithhelicobacterpyloriinfectionover13yearsinnorthernitaly AT gismondipierpacifico primaryantimicrobialsusceptibilitychangesinchildrenwithhelicobacterpyloriinfectionover13yearsinnorthernitaly AT maffinivalentina primaryantimicrobialsusceptibilitychangesinchildrenwithhelicobacterpyloriinfectionover13yearsinnorthernitaly AT bizzarribarbara primaryantimicrobialsusceptibilitychangesinchildrenwithhelicobacterpyloriinfectionover13yearsinnorthernitaly AT fornarolifabiola primaryantimicrobialsusceptibilitychangesinchildrenwithhelicobacterpyloriinfectionover13yearsinnorthernitaly AT madiacarmen primaryantimicrobialsusceptibilitychangesinchildrenwithhelicobacterpyloriinfectionover13yearsinnorthernitaly AT salernoantonino primaryantimicrobialsusceptibilitychangesinchildrenwithhelicobacterpyloriinfectionover13yearsinnorthernitaly AT cangelosiamarta primaryantimicrobialsusceptibilitychangesinchildrenwithhelicobacterpyloriinfectionover13yearsinnorthernitaly AT deangelisgianluigi primaryantimicrobialsusceptibilitychangesinchildrenwithhelicobacterpyloriinfectionover13yearsinnorthernitaly |